Investor List:

Top Pharmaceuticals Series B Investors in Boston / New England (6)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Bill Helman, Partner at Greylock
Bill Helman
Greylock·Partner
Sweet spot: $25.0M
Range: $500K - $200.0M
Investors in Boston (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Enterprise, Investors in Pharmaceuticals
Photo of Dylan Morris, General Partner at CRV
Dylan Morris
CRV·General Partner
Sweet spot: $13.0M
Range: $500K - $20.0M
Investors in SF Bay Area (CA), Investors in Boston / New England
Investors in BioTech, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of David Schenkein, General Partner at GV
David Schenkein
GV·General Partner
Sweet spot: $25.0M
Range: $250K - $50.0M
Investors in Boston (MA), Investors in Boston / New England
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals
Photo of Daniel Lynch, Venture Partner at GV
Daniel Lynch
GV·Venture Partner
Sweet spot: $25.0M
Range: $250K - $50.0M
Investors in Boston (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals
Photo of Keith Gottesdiener, Venture Partner at Samsara BioCapital
Keith Gottesdiener
Samsara BioCapital·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $100.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals
Photo of Rosana Kapeller, Investor at GV
Rosana Kapeller
GV·Investor
Sweet spot: $25.0M
Range: $250K - $50.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals
Get new data & insights delivered to your inbox
Firms investing in this space